Americas (WHO region) vs Zambia: Number of people protected from malaria by indoor residual spraying
Americas (WHO region)
2.41 million
in 2021
Zambia
3.91 million
in 2024
Americas (WHO region) rank
5th
Zambia rank
5th
Number of people protected from malaria by indoor residual spraying over time
- Americas (WHO region)
- Zambia
How they compare
Zambia currently reports 3.91 million against 2.41 million in Americas (WHO region), a difference of 1.50 million.
That makes Zambia's figure about 1.6 times Americas (WHO region)'s.
Across all 7 years both countries report, Zambia has been ahead every year.
Americas (WHO region) ranks 5th and Zambia ranks 5th of 6 groups.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.20 million | 7.72 million | 5.52 million | Zambia |
| 2020s | 1.72 million | 10.95 million | 9.23 million | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people protected from malaria by indoor residual spraying, Americas (WHO region) or Zambia?
- Zambia, at 3.91 million against 2.41 million in Americas (WHO region) as of 2024.
- What is the difference in number of people protected from malaria by indoor residual spraying between Americas (WHO region) and Zambia?
- 1.50 million, with Zambia ahead.
- How many years of comparable data are there for Americas (WHO region) and Zambia?
- 7 years are reported by both, from 2015 to 2021.
- How do Americas (WHO region) and Zambia rank globally for number of people protected from malaria by indoor residual spraying?
- Americas (WHO region) ranks 5th and Zambia ranks 5th of 6 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of people protected from malaria by indoor residual spraying (IRS). Statizoid refreshes it automatically from the source and publishes the full history for both places.